What Nurix Therapeutics, Inc. pays on H-1B filings
Nurix Therapeutics, Inc. filed 18 certified H-1B LCAs in FY2025-FY2026. Each one states the wage the employer will pay for a role at a worksite. Grouped by title below: what the employer stated, not what any one person earned.
FY2026 so far · 5 LCAsFY2025 · 13 LCAs
Stated wages by title
| Title | LCAs | Year | Typical range | Median |
|---|---|---|---|---|
| Research Associate | 5 | FY2025 | $114,500 to $115,000 | $115,000 |
| Associate Director | 4 | FY2025 | $140,000 to $166,250 | $152,500 |
Typical range is the middle half of that year's filings, or the full span when there are fewer than four. LCA counts cover FY2025-FY2026.
Filings by fiscal year
| Fiscal year | Certified LCAs |
|---|---|
| FY2026 (October to June) | 5 |
| FY2025 | 13 |
By prevailing-wage level
| Level | LCAs | Median stated wage |
|---|---|---|
| Level II (qualified) | 6 | $115,000 |
| Level III (experienced) | 8 | $140,000 |
| Level IV (fully competent) | 4 | $165,000 |
DOL sets four prevailing-wage levels for each job and place, from entry (I) to fully competent (IV). The level is the employer's own classification of the position.
Top worksites
| Worksite | LCAs | Median stated wage |
|---|---|---|
| San Francisco, CA | 9 | $140,000 |
| Brisbane, CA | 5 | $150,000 |
| Menlo Park, CA | 1 | $140,000 |
| Monrovia, MD | 1 | $140,000 |
Looking at Nurix Therapeutics, Inc.?
Nyanza shows these filings next to any posting you check, with the employer's H-1B approval history, so you can ask the right questions early.